The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 328.00
Bid: 325.50
Ask: 330.00
Change: 28.00 (9.33%)
Spread: 4.50 (1.382%)
Open: 304.00
High: 350.00
Low: 303.00
Prev. Close: 300.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

Fri, 08th Jan 2021 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

----------

FTSE 100

----------

UBS CUTS NEXT TO 'NEUTRAL' (BUY) - PRICE TARGET 8,100 (6,550) PENCE

----------

BARCLAYS CUTS AB FOODS PRICE TARGET TO 2,600 (2,700) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES J SAINSBURY PRICE TARGET TO 270 (250) PENCE - 'BUY'

----------

RBC RAISES ENTAIN PRICE TARGET TO 1,700 (1,475) PENCE - 'OUTPERFORM'

----------

GOLDMAN RAISES ENTAIN PRICE TARGET TO 1,620 (1,530) PENCE - 'BUY'

----------

UBS CUTS INTERCONTINENTAL HOTELS PRICE TARGET TO 4,200 (4,300) PENCE - 'SELL'

----------

UBS RAISES WHITBREAD PRICE TARGET TO 3,550 (3,200) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES BARRATT DEVELOPMENTS PRICE TARGET TO 735 (634) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE RAISES SHELL PRICE TARGET TO 1,715 (1,550) PENCE - 'OUTPERFORM'

----------

GOLDMAN CUTS BAE SYSTEMS PRICE TARGET TO 531 (538) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS ROLLS-ROYCE PRICE TARGET TO 126 (127) PENCE - 'BUY'

----------

JPMORGAN RAISES CRH PRICE TARGET TO 41 (40) EUR - 'OVERWEIGHT'

----------

SHORE CAPITAL RAISES HARGREAVES LANSDOWN TO 'BUY' ('HOLD'); FAIR VALUE 1,850 (1,625) PENCE

----------

BARCLAYS CUTS HARGREAVES LANSDOWN PRICE TARGET TO 1,925 (2,010) PENCE - 'OVERWEIGHT'

----------

FTSE 250

----------

UBS RAISES SSP GROUP PRICE TARGET TO 405 (340) PENCE - 'BUY'

----------

GOLDMAN RAISES SSP GROUP PRICE TARGET TO 340 (260) PENCE - 'NEUTRAL'

----------

UBS RAISES GREGGS PRICE TARGET TO 2,190 (1,930) PENCE - 'BUY'

----------

JPMORGAN RAISES TRAVIS PERKINS TO 'NEUTRAL' ('UNDERWEIGHT') - TARGET 1,390 (1,100) PENCE

----------

JPMORGAN RAISES IBSTOCK PRICE TARGET TO 203 (175) PENCE - 'NEUTRAL'

----------

BARCLAYS RAISES ROYAL MAIL PRICE TARGET TO 350 (300) PENCE - 'OVERWEIGHT'

----------

LIBERUM RAISES OXFORD BIOMEDICA PRICE TARGET TO 1,280 (1,050) PENCE - 'BUY'

----------

JEFFERIES RAISES OXFORD BIOMEDICA PRICE TARGET TO 950 (860) PENCE - 'HOLD'

----------

GOLDMAN RAISES TI FLUIDS PRICE TARGET TO 243 (200) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS ULTRA ELECTRONICS PRICE TARGET TO 1,687 (1,732) PENCE - 'SELL'

----------

GOLDMAN CUTS QINETIQ PRICE TARGET TO 305 (308) PENCE - 'SELL'

----------

CREDIT SUISSE RAISES MAN GROUP PRICE TARGET TO 160 (150) PENCE - 'OUTPERFORM'

----------

BARCLAYS RAISES PRIMARY HEALTH PROPERTIES PRICE TARGET TO 175 (170) PENCE - 'OVERWEIGHT'

----------

LIBERUM RAISES CLARKSON PRICE TARGET TO 3,100 (3,000) PENCE - 'BUY'

----------

GOLDMAN CUTS ASTON MARTIN PRICE TARGET TO 807 (940) PENCE - 'SELL'

----------

JPMORGAN CUTS BABCOCK INTERNATIONAL PRICE TARGET TO 335 (400) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS MEGGITT PRICE TARGET TO 390 (395) PENCE - 'NEUTRAL'

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM RAISES TYMAN PRICE TARGET TO 400 (320) PENCE - 'BUY'

----------

SHORE CAPITAL INITIATES COVERAGE OF discoverIE AT BUY 800 PENCE FAIR VALUE

----------

SHORE CAPITAL MARKETS WITHDRAWS COVERAGE OF RANDALL & QUILTER

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Apr 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
6 Apr 2021 08:19

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Read more
6 Apr 2021 08:08

Oxford Biomedica strikes three-year deal with Boehringer Ingelheim

(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a new three-year development and supply agreement with Boehringer Ingelheim, it announced on Tuesday, for the manufacture and supply of various types of viral vectors.

Read more
6 Apr 2021 07:53

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

Read more
21 Mar 2021 20:57

EU rebuffs UK calls to ship AstraZeneca COVID vaccines from Europe

By Francesco GuarascioBRUSSELS, March 21 (Reuters) - The European Union is rebuffing British government calls to ship AstraZeneca COVID-19 vaccines produced in a factory in the Netherlands, an EU official said on Sunday.Former EU member Britain ha...

Read more
19 Mar 2021 10:29

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Read more
19 Mar 2021 07:50

Oxford Biomedica says Sanofi pulling out of haemophilia project

(Sharecast News) - Oxford Biomedica said that Sanofi's decision to terminate collaboration on a haemophilia treatment would have a "negligible" impact on revenue.

Read more
3 Feb 2021 13:56

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

Read more
29 Jan 2021 09:11

UPDATE 1-EU holds out for more after AstraZeneca offered 8 mln extra COVID-19 shots

* Astra had committed to at least 80 mln shots in Q1* EU funded two UK plants under deal with Astra - sources* Astra says UK has priority for doses produced there (Adds detail, background)By Francesco Guarascio and Sabine SieboldBRUSSELS, Jan 29 (Re...

Read more
18 Jan 2021 17:18

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

Read more
8 Dec 2020 12:31

UK's initial AstraZeneca shots will come from Europe, taskforce says

By Alistair SmoutLONDON, Dec 8 (Reuters) - Britain's initial doses of the COVID-19 vaccine candidate developed by AstraZeneca and Oxford University will come from Europe rather than a domestic supply chain, the country's Vaccine Taskforce said.The...

Read more
1 Dec 2020 14:29

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

Read more
9 Nov 2020 10:01

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Read more
9 Nov 2020 09:16

Oxford Biomedica strikes collaboration agreement with PhoreMost

(Sharecast News) - Gene and cell therapy group Oxford Biomedica has inked a discovery collaboration agreement with UK-based biopharmaceutical company PhoreMost.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.